Moderna Inc
NASDAQ:MRNA
Moderna Inc
NASDAQ:MRNA
Price:
49.04
USD
-1.98%
Market Closed
Market Cap:
$19.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Moderna Inc
NASDAQ:MRNA
|
US |
|
P
|
Polytec Holding AG
VSE:PYT
|
AT |
|
Delek Logistics Partners LP
NYSE:DKL
|
US |
|
First Quantum Minerals Ltd
TSX:FM
|
CA |
|
Black Diamond Therapeutics Inc
NASDAQ:BDTX
|
US |
|
W
|
Wharf Real Estate Investment Company Ltd
HKEX:1997
|
HK |
|
H
|
Heidelberg Materials AG
SWB:HEI
|
DE |
|
Taylor Devices Inc
NASDAQ:TAYD
|
US |
Wall St Price Targets
MRNA Price Targets Summary
Moderna Inc
Moderna Inc
Wall Street analysts forecast MRNA stock price to drop over the next 12 months.
According to Wall Street analysts, the average 1-year price target for MRNA is 49.02 USD with a low forecast of 21.21 USD and a high forecast of 141.75 USD.
Lowest Forecast
Price Target
21.21
USD
57% Downside
Average Forecast
Price Target
49.02
USD
0% Downside
Highest Forecast
Price Target
141.75
USD
189% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MRNA's stock price target?
Price Target
49.02
USD
49.02
USD
According to Wall Street analysts, the average 1-year price target for MRNA is 49.02 USD with a low forecast of 21.21 USD and a high forecast of 141.75 USD.
What is the Revenue forecast for Moderna Inc?
Projected CAGR
19%
19%
Over the last 8 years, the compound annual growth rate for Revenue has been 32%. The projected CAGR for the next 8 years is 19%.
